Literature DB >> 22104642

Modulation transfer function and optical quality after bilateral implantation of a +3.00 D versus a +4.00 D multifocal intraocular lens.

Marcony R Santhiago1, Steven E Wilson, Marcelo V Netto, Ramon C Ghanen, Mario Luis R Monteiro, Samir J Bechara, Edgar M Espana, Glauco R Mello, Newton Kara.   

Abstract

PURPOSE: To determine whether the improvement in intermediate vision after bilateral implantation of an aspheric multifocal intraocular lens (IOL) with a +3.00 diopter (D) addition (add) occurs at the expense of optical quality compared with the previous model with a +4.00 D add.
SETTING: Department of Ophthalmology, University of São Paulo, São Paulo, Brazil.
DESIGN: Prospective randomized double-masked comparative clinical trial.
METHODS: One year after bilateral implantation of Acrysof Restor SN6AD1 +3.00 D IOLs or Acrysof Restor SN6AD3 +4.00 D IOLs, optical quality was evaluated by analyzing the in vivo modulation transfer function (MTF) and point-spread function (expressed as Strehl ratio). The Strehl ratio and MTF curve with a 4.0 pupil and a 6.0 mm pupil were measured by dynamic retinoscopy aberrometry. The uncorrected and corrected distance visual acuities at 4 m, uncorrected and distance-corrected near visual acuities at 40 cm, and uncorrected and distance-corrected intermediate visual acuities at 50 cm, 60 cm, and 70 cm were measured.
RESULTS: Both IOL groups comprised 40 eyes of 20 patients. One year postoperatively, there were no statistically significant between-group differences in the MTF or Strehl ratio with either pupil size. There were no statistically significant between-group differences in distance or near visual acuity. Intermediate visual acuity was significantly better in the +3.00 D IOL group.
CONCLUSION: Results indicate that the improvement in intermediate vision in eyes with the aspheric multifocal + 3.00 D add IOL occurred without decreasing optical quality over that with the previous version IOL with a +4.00 D add.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22104642     DOI: 10.1016/j.jcrs.2011.08.029

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  In vitro optical quality comparison between the Mini WELL Ready progressive multifocal and the TECNIS Symfony.

Authors:  Alberto Domínguez-Vicent; Jose Juan Esteve-Taboada; Antonio J Del Águila-Carrasco; Teresa Ferrer-Blasco; Robert Montés-Micó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-16       Impact factor: 3.117

2.  Visual and optical performances of multifocal intraocular lenses with three different near additions: 6-month follow-up.

Authors:  Mengmeng Wang; Christine Carole C Corpuz; Megumi Fujiwara; Minoru Tomita
Journal:  Open Ophthalmol J       Date:  2015-01-30

3.  Evaluation of optical quality parameters and ocular aberrations in multifocal intraocular lens implanted eyes.

Authors:  Hun Lee; Kwanghyun Lee; Ji Min Ahn; Eung Kweon Kim; Bradford Sgrignoli; Tae-im Kim
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

4.  Visual outcomes and patient satisfaction after refractive lens exchange with a single-piece diffractive multifocal intraocular lens.

Authors:  John S M Chang; Jack C M Ng; Vincent K C Chan; Antony K P Law
Journal:  J Ophthalmol       Date:  2014-11-23       Impact factor: 1.909

5.  Utility of the optical quality analysis system for decision-making in cataract surgery.

Authors:  Jin Sun Hwang; Yoon Pyo Lee; Seok Hyun Bae; Ha Kyoung Kim; Kayoung Yi; Young Joo Shin
Journal:  BMC Ophthalmol       Date:  2018-09-03       Impact factor: 2.209

6.  Characterization of optical performance with defocusing curve: Analysis of two refractive intraocular lens models with high and medium addition.

Authors:  Jorge A Calvo-Sanz; Miguel A Sánchez-Tena
Journal:  J Optom       Date:  2018-11-01

7.  Comparative visual performance with monofocal and multifocal intraocular lenses.

Authors:  Kjell Gunnar Gundersen; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2013-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.